rtsl.jpg
Rapid Therapeutic Enters Letter of Intent to Expand Production Capability to 3,000,000 MDI and $100,000,000 in Revenue Annually
September 30, 2020 06:00 ET | Rapid Therapeutic Science Laboratories
DALLAS, Sept. 30, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing and marketing company focused on...
rtsl.jpg
Rapid Therapeutic Announces Completion of New ISO 13485 Laboratory
August 18, 2020 07:00 ET | Rapid Therapeutic Science Laboratories
DALLAS, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing and marketing company focused on...
Hemp Products Powered By VESIsorb
Geocann inks supply and distribution agreement with Opticann, a new U.S.-based company founded by former MedReleaf executives
August 06, 2020 16:00 ET | Geocann
FORT COLLINS, Colo., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Geocann is proud to announce a strategic partnership with Opticann Inc. (“Opticann”) that will bring VESIsorb® formulated hemp products into...
rtsl.jpg
Rapid Therapeutic Science Laboratories (RTSL), Inc. engages Ezzey Digital Marketing Agency to Launch its New Lifestyle Brand “nhāler”
August 06, 2020 07:00 ET | Rapid Therapeutic Science Laboratories
DALLAS, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL), an SEC fully-reporting, growth-oriented manufacturing and marketing company focused on employing...
rtsl.jpg
Rapid Therapeutic Science Files with FDA to Register Facility and Products DALLAS, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented manufacturing and marketing company focused on employing...
rtsl.jpg
Rapid Therapeutic Completes Delivery of Additional 6,000 Units of its Proprietary Metered Dose Inhalers DALLAS, July 14, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented manufacturing and marketing company focused on employing...
rtsl.jpg
Rapid Therapeutic Announces Major Contract is Increased by 150% to 250,000 Metered Dose Inhalers DALLAS, July 09, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL), a fully-reporting, early stage, emerging biotech company focused on aerosol delivery of...
rtsl.jpg
Rapid Therapeutic Completes Initial Delivery of 2,000 Units of its Proprietary Metered Dose Inhalers DALLAS, July 08, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented company focused on manufacturing and marketing aerosol...
exactus-logo (1) (002).png
Exactus, Inc. Reports First Quarter 2020 Financial Results
July 01, 2020 09:14 ET | Exactus Inc.
First Quarter 2020 Highlights Total Net Revenue of $836,000Continuation of Sales & Marketing BuildoutRestructuring of Company and Board of DirectorsBegan Biomass Inventory Extraction...
Veritas.png
Veritas Farms Announces Commencement of 2020 Outdoor Planting Season and Implementation of Significant Improvements to Farming Practices and Genetics Program
June 10, 2020 08:22 ET | Veritas Farms, Inc.
Fort Lauderdale, FL, June 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Veritas Farms, Inc. (OTCQB: VFRM) (“Veritas Farms” or the “Company”), a vertically integrated agribusiness focused on the...